iSpecimen Inc (ISPC) - Total Assets
Based on the latest financial reports, iSpecimen Inc (ISPC) holds total assets worth $9.53 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See iSpecimen Inc book value and equity for net asset value and shareholders' equity analysis.
iSpecimen Inc - Total Assets Trend (2018–2025)
This chart illustrates how iSpecimen Inc's total assets have evolved over time, based on quarterly financial data.
iSpecimen Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
iSpecimen Inc's total assets of $9.53 Million consist of 73.0% current assets and 27.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 72.2% |
| Accounts Receivable | $48.30K | 0.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.00 Million | 10.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how iSpecimen Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ISPC stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: iSpecimen Inc's current assets represent 73.0% of total assets in 2025, an increase from 57.0% in 2018.
- Cash Position: Cash and equivalents constituted 72.2% of total assets in 2025, up from 28.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, a decrease from 35.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 10.5% of total assets.
iSpecimen Inc Competitors by Total Assets
Key competitors of iSpecimen Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.17 Billion |
|
INTERGRATED DIA.H DL 025
F:8I8
|
Germany | €6.77 Billion |
|
Immunovia publ AB
ST:IMMNOV
|
Sweden | Skr88.21 Million |
|
IZOTROPIC CORP.
F:1R3
|
Germany | €685.34K |
|
Wellfully Ltd
AU:WFL
|
Australia | AU$3.51 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
iSpecimen Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.12 | 0.31 | 2.86 |
| Quick Ratio | 1.12 | 0.31 | 2.86 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $723.28K | $-3.39 Million | $10.99 Million |
iSpecimen Inc - Advanced Valuation Insights
This section examines the relationship between iSpecimen Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.30 |
| Latest Market Cap to Assets Ratio | 0.48 |
| Asset Growth Rate (YoY) | 1.9% |
| Total Assets | $9.53 Million |
| Market Capitalization | $4.54 Million USD |
Valuation Analysis
Below Book Valuation: The market values iSpecimen Inc's assets below their book value (0.48x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: iSpecimen Inc's assets grew by 1.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for iSpecimen Inc (2018–2025)
The table below shows the annual total assets of iSpecimen Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $9.53 Million | +1.94% |
| 2024-12-31 | $9.35 Million | -40.89% |
| 2023-12-31 | $15.82 Million | -35.74% |
| 2022-12-31 | $24.62 Million | -31.08% |
| 2021-12-31 | $35.72 Million | +475.22% |
| 2020-12-31 | $6.21 Million | +47.34% |
| 2019-12-31 | $4.21 Million | +4.20% |
| 2018-12-31 | $4.04 Million | -- |
About iSpecimen Inc
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have ac… Read more